As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Scholar Rock Holding Corporation. The largest reported stake is Invus Public Equities, L.P.'s, at 8%. 9 filings are on record since August 14, 2025 (Schedule 13G/A, August 13, 2026).
Sell to companies like Scholar Rock Holding Corporation? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Redmile Group, LLC · Sole voting: 0 · Shared voting: 4,311,092 · Sole dispositive: 0 · Shared dispositive: 4,311,092 · SCHEDULE 13G/A, 2026-08-14
- · Reporting person: Invus Public Equities, L.P. · Sole voting: 9,575,013 · Shared voting: 0 · Sole dispositive: 9,575,013 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-13
- · Reporting person: T. Rowe Price Associates, Inc. · Sole voting: 6,203,887 · Shared voting: 0 · Sole dispositive: 6,206,044 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-05-15
- · Holder: Redmile Group, LLC · Percent: 7.6% · SCHEDULE 13G/A
- · Holder: The Vanguard Group · Percent: 0% · SCHEDULE 13G/A
Scholar Rock Holding Corporation has 9 Schedule 13D or 13G filings on record since 2025-08-14. 4 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Invus Public Equities, L.P. | 8% | 9,575,013 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
| Samsara BioCapital, L.P. | 7.2% | 6,367,614 | SCHEDULE 13D/A, 2025-10-07 | 2025-10-03 |
| Wellington Management Group LLP | 5.6% | 5,759,428 | SCHEDULE 13G, 2026-02-10 | 2025-12-31 |
| T. Rowe Price Associates, Inc. | 5.4% | 6,206,044 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Redmile Group, LLC | 3.6% | 4,311,092 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Scholar Rock Holding Corporation and the warning signs.
Free to see. No signup.
Keep reading
More on Scholar Rock Holding Corporation and the records around it.
Scholar Rock Holding Corporation elsewhere on the record
Companies that share a holder
- Samsara BioCapital, L.P. also filed stake reports on 14 other companies: PMV Pharmaceuticals, Inc. (Sep 2026), Eloxx Pharmaceuticals, Inc. (Aug 2026), RANI THERAPEUTICS HOLDINGS, INC. (May 2026)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- Invus Public Equities, L.P. also filed stake reports on 24 other companies: City Therapeutics, Inc. (Oct 2026), Yarrow Bioscience, Inc. (Sep 2026), Abivax S.A. (Aug 2026)
Watch Scholar Rock Holding Corporation
Get an email when Scholar Rock Holding Corporation files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Scholar Rock Holding Corporation?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Scholar Rock Holding Corporation: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Scholar Rock Holding Corporation covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 9,575,013 | 0 | 9,575,013 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| Invus Public Equities Advisors, LLC | 9,575,013 | 0 | 9,575,013 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| Invus Global Management, LLC | 9,575,013 | 0 | 9,575,013 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| Siren, L.L.C. | 9,575,013 | 0 | 9,575,013 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| Raymond Debbane | 9,575,013 | 0 | 9,575,013 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| T. Rowe Price Associates, Inc. | 6,203,887 | 0 | 6,206,044 | 0 | SCHEDULE 13G/A, 2026-05-15 |
| Redmile Group, LLC | 0 | 4,311,092 | 0 | 4,311,092 | SCHEDULE 13G/A, 2026-08-14 |
| Jeremy C. Green | 0 | 4,311,092 | 0 | 4,311,092 | SCHEDULE 13G/A, 2026-08-14 |
| RedCo II Master Fund, L.P. | 0 | 0 | 0 | 0 | SCHEDULE 13G/A, 2026-08-14 |
The latest filing identifies Scholar Rock Holding Corporation by CUSIP 80706P103 and gives its principal executive office as 301 Binney Street, 3rd Floor, Cambridge, MA 02142 (SCHEDULE 13G/A, 2026-08-14).
What the percentages are based on
As of June 30, 2026, each of the Reporting Persons may be deemed to be the beneficial owner of the Shares listed on such Reporting Person's cover page. Calculations of the percentage of Shares beneficially owned are based on 119,828,338 Shares outstanding as of May 4, 2026 as reported by the Issuer in its quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026.Invus Public Equities, L.P., SCHEDULE 13G/A, 2026-08-13
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | T. Rowe Price Associates, Inc. | 9.2% | SCHEDULE 13G/A |
| 2025-10-07 | Samsara BioCapital, L.P. | 7.2% | SCHEDULE 13D/A |
| 2025-11-14 | T. Rowe Price Associates, Inc. | 7.2% | SCHEDULE 13G/A |
| 2026-02-10 | Wellington Management Group LLP | 5.6% | SCHEDULE 13G |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-15 | T. Rowe Price Associates, Inc. | 5.4% | SCHEDULE 13G/A |
| 2026-05-15 | Redmile Group, LLC | 7.6% | SCHEDULE 13G/A |
| 2026-08-13 | Invus Public Equities, L.P. | 8% | SCHEDULE 13G/A |
| 2026-08-14 | Redmile Group, LLC | 3.6% | SCHEDULE 13G/A |
Questions about who owns Scholar Rock Holding Corporation
Who owns Scholar Rock Holding Corporation?
On this page, 4 holders' latest ownership filings report 5% or more of Scholar Rock Holding Corporation: Invus Public Equities, L.P. (8%, Schedule 13G/A, filed 2026-08-13), Samsara BioCapital, L.P. (7.2%, Schedule 13D/A, filed 2025-10-07), Wellington Management Group LLP (5.6%, Schedule 13G, filed 2026-02-10) and T. Rowe Price Associates, Inc. (5.4%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of Scholar Rock Holding Corporation?
By the share each holder's latest filing reports, the largest holders of Scholar Rock Holding Corporation on this page are Invus Public Equities, L.P. (8%), Samsara BioCapital, L.P. (7.2%) and Wellington Management Group LLP (5.6%).
When did Invus Public Equities, L.P. buy into Scholar Rock Holding Corporation?
The filings give report dates, not purchase dates. The earliest filing from Invus Public Equities, L.P. on this page is the Schedule 13G/A, filed 2026-08-13, reporting 8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Scholar Rock Holding Corporation. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.